Sorucu Ali, Gokbulut Cengiz, Aslan Akyol Busra, Bulut Osman
Department of Pharmacology and Toxicology, Faculty of Milas Veterinary Medicine, Muğla Sitki Koçman University, 48200 Muğla, Türkiye.
Beekeeping and Silkworm Research and Application Centre, Muğla Sıtkı Koçman University, 48200 Muğla, Türkiye.
Pharmaceuticals (Basel). 2025 Jun 27;18(7):967. doi: 10.3390/ph18070967.
Propolis is a natural resinous substance produced by honeybees that has many biological activities. For thousands of years, it has been widely used as a dietary supplement and traditional medicine to treat a variety of ailments due to its antimicrobial, anti-inflammatory, antioxidant, immunomodulatory, and wound-healing properties. Nutritional supplements and foods may interact with drugs both pharmacodynamically and pharmacokinetically, which could raise clinical concerns. : This study aimed to investigate the effect of propolis on the plasma disposition of enrofloxacin and to assess the potential pharmacokinetic interaction in rabbits. : In this study, enrofloxacin was applied per os (20 mg/kg) and IM (10 mg/kg) and with propolis (100 mg resin/kg) administration in four groups of rabbits (each of six individuals). Heparinized blood samples were collected at 0, 0.1, 0.3, 0.5, 1, 2, 4, 8, 12, and 24 h post-administration. HPLC-FL was used to analyze the plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin following liquid-liquid phase extraction, i.e., protein precipitation with acetonitrile and partitioning with sodium sulfate. : The results revealed that propolis coadministration significantly affected the plasma disposition of enrofloxacin and its active metabolite after both per os and intramuscular administration routes. Significantly greater AUC (48.91 ± 11.53 vs. 26.11 ± 12.44 µg.h/mL), as well as longer T (11.75 ± 3.20 vs. 5.93 ± 2.51 h) and MRT (17.26 ± 4.55 vs. 8.96 ± 3.82 h) values of enrofloxacin and its metabolite ciprofloxacin, were observed after the coadministration of propolis compared to enrofloxacin alone following both per os and IM routes in rabbits. : The concurrent use of propolis and prescription medications may prolong the half-life (T) and increase the systemic availability of chronically used drugs with narrow therapeutic indices. The repeated use of drugs such as antibiotics, heart medications, and antidepressants, or drugs with a narrow therapeutic index such as antineoplastic and anticoagulant agents, can cause toxic effects by raising blood plasma levels. Considering the varied metabolism of rabbits and humans, further validation of this study may require thorough clinical trials in humans.
蜂胶是蜜蜂产生的一种天然树脂状物质,具有多种生物活性。数千年来,由于其抗菌、抗炎、抗氧化、免疫调节和伤口愈合特性,它一直被广泛用作膳食补充剂和传统药物来治疗各种疾病。营养补充剂和食物可能在药效学和药代动力学方面与药物相互作用,这可能引发临床关注。本研究旨在调查蜂胶对恩诺沙星血浆处置的影响,并评估家兔中潜在的药代动力学相互作用。在本研究中,对四组家兔(每组六只)分别经口(20毫克/千克)和肌肉注射(10毫克/千克)给予恩诺沙星,并同时给予蜂胶(100毫克树脂/千克)。给药后0、0.1、0.3、0.5、1、2、4、8、12和24小时采集肝素化血样。采用高效液相色谱-荧光法(HPLC-FL),通过液-液萃取,即使用乙腈进行蛋白沉淀和用硫酸钠进行分配,来分析恩诺沙星及其活性代谢物环丙沙星的血浆浓度。结果显示,在经口和肌肉注射给药途径后,同时给予蜂胶均显著影响恩诺沙星及其活性代谢物的血浆处置。与单独给予恩诺沙星相比,家兔经口和肌肉注射途径同时给予蜂胶后,恩诺沙星及其代谢物环丙沙星的曲线下面积(AUC)显著更大(48.91±11.53对26.11±12.44微克·小时/毫升),以及达峰时间(T)更长(11.75±3.20对5.93±2.51小时)和平均滞留时间(MRT)更长(17.26±4.55对8.96±3.82小时)。同时使用蜂胶和处方药可能会延长半衰期(T),并增加治疗指数窄的长期使用药物的全身可用性。重复使用抗生素、心脏药物和抗抑郁药等药物,或使用治疗指数窄的药物如抗肿瘤和抗凝剂,可能会通过提高血浆水平而导致毒性作用。考虑到家兔和人类代谢的差异,本研究可能需要在人体中进行全面的临床试验以进一步验证。